What To Do With Celgene Now With Major Catalysts Gone
October 20, 2017 at 09:44 AM EDT
Celgene Corporation (NASDAQ: CELG)’s discontinuation of mongerson for Crohn’s disease is decidedly negative. The stock ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.